A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters

Acta Neurologica Scandinavica

Volumn 98, Issue 6, 1998, Pages 395-399

  Munch, M ^a   Hvas, J ^a   Christensen, T ^a   Moller Larsen, A ^a   Haahr, S ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Cluster; Epidemiology; Epstein Barr virus; Multiple sclerosis; Type

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DENMARK; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; VIRUS TYPING;

EID: 0032423861     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb07320.x     Document Type: Article

References (25)

1. KURTZKE JF. Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6:382-427.
2. GALE CR, MARTYN CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995;47:425-48.
3. OPERSKALSKI EA, VISSCHER BR, MALMGREN RM, DETELS R. A case-control study of multiple sclerosis. Neurology 1989;34:825-9.
4. MARTYN C, CRUDAS M, COMPSTON DAS. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:167-8.
5. HAAHR S, KOCH-HENRIKSEN N, MDLLER-LARSEN A, ERIKSEN LS, ANDERSEN HMK. Increased risk of multiple sclerosis after late Epstein-Barr virus infection. Multiple Sclerosis 1995;l:73-7.
6. RUSE T, GRONNING M, KLAUBER MR, BARRETT-CONNOR E, NYLAND H, ALBREKTSEN G. Clustering of residence of multiple sclerosis patients at age 13-20 years in Hordaland, Norway. Am J Epidemiol 1991;133:932-9.
7. HAAHR S, MUNCH M, CIIRISTENSEN T, MOLLER-LARSEN A, HVAS J. Cluster of multiple sclerosis patients from Danish community. Lancet 1997;349:923.
8. KNOX EG. Detection of clusters In: ELLIOT P, ed. Methodology of enquiries into disease clustering. London. Small Area Health Statistics Unit 1989:17-20.
9. FALK K, GRATAMA JW, ROWE M et al. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J Gen Virol 1995;76:119-790.
10. FALK K, Zou JZ, Lucirr E, LINDE A, ERNBERO I. Direct identification by PCR of EBV types and variants in clinical samples. J Med Virol 1997;51:355-63.
11. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis guidelines for research protocols. Ann Neurol 1983; 13:227-31.
12. LARSEN PD, BLOOMER LC, BRAY PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titres in multiple sclerosis. Neurology 1985;35:435-8.
13. SUMAYA CV, MYERS LW, ELLISON GW, ENCH Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985;17: 371-7.
14. ROWE M, YOUNG LS, CADWALLADER K, PETTI L, KIEFF E, RICKINSON AB. Distinction of Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J Virol 1989;63:1031-9.
15. SAMPLE J, YOUNG L, MARTIN B et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990;64:40S4-92.
16. RUSE T. Cluster studies in multiple sclerosis. Neurology 1997;49 (Suppl 2):S27-S32.
17. DECKER LL, KLAMAN LD, THORLEY-LAWSON DA. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 1996; 70:3286-9.
18. SAITO I, SEVENIUS B, COMPTON T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's Syndrome. J Exp Med 1989:2191-8.
19. MUNCH M, MOLLER-LARSEN A, CHRISTENSEN T, MORLING N, HANSEN HJ, HAAHR S. B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Multiple Sclerosis 1995;1:78-S1.
20. FRASER KB, HAIRE M, MILLAR JHD, McCREA S. Increased tendency to spontaneous in vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet 1979; ii:715-7.
21. MUNCH M, RIISOM K, CHRISTENSEN T, MDLLER-LARSEN A, HAAHR S. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?. Acta Neurol Scand 1998;97:171-4.
22. HAAHR S, SOMMERLUND M, MOLLER-LARSEN A, MOGENSEN S, ANDERSEN HMK. Multiple sclerosis is caused by a dual infection with retrovirus and Epstein-Barr virus?. Neuroepidemiology 1993;11:299-303.
23. CHRISTENSEN T, JENSEN AW, MUNCH M et al. Characterisation of retroviruses from patients with multiple sclerosis. Acta Neurol Scand Suppl 1997;!69:49-58.
24. CHRISTENSEN T, DISSING SORENSEN P, RIEMAN H, HANSEN HJ, MDLLER-LARSEN A. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet. (In press).
25. MUNCH M, HVAS J, CHRISTENSEN T, MOLLER-LARSEN A, HAAHR S. The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand Suppl 1997;169:59-64.